Skip to main content

Correction: Semaglutide restores astrocyte-vascular interactions and blood-brain barrier integrity in a model of diet-induced metabolic syndrome

The Original Article was published on 04 January 2025

Correction: Diabetology & Metabolic Syndrome (2025) 17:2

https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13098-024-01528-0

In this article Fig. 5 appeared incorrectly and has now been corrected in the original publication. For completeness and transparency, the old incorrect versions are displayed below.

Incorrect Fig. 5.

Fig. 5
figure a

Graphical representation of the AngioTool analysis of cerebral cortex sections (A) and hippocampal sections (D) from mice fed a high-fat (HFD) or normolipid (ND) diet and treated subcutaneously with 0.2 mg/kg/day semaglutide (SEMA) or saline solution (SAL). Average vessel length in the cortical area and hippocampus (B and E) and lacunarity in the cortical area and hippocampus (C and F). The skeleton is shown in red, and the branching points are shown in blue. Vessels labeled with IB4. Magnification: 400x; scale bar, 50 μm for all images. n = 6. *p < 0.05 versus the ND SAL group; #p < 0.05 versus the HFD SAL group

Corrected Fig. 5.

Fig. 5
figure b

Graphical representation of the AngioTool analysis of cerebral cortex sections (A) and hippocampal sections (D) from mice fed a high-fat (HFD) or normolipid (ND) diet and treated subcutaneously with 0.2 mg/kg/day semaglutide (SEMA) or saline solution (SAL). Average vessel length in the cortical area and hippocampus (B and E) and lacunarity in the cortical area and hippocampus (C and F). The skeleton is shown in red, and the branching points are shown in blue. Vessels labeled with IB4. Magnification: 400x; scale bar, 50 μm for all images. n = 6. *p < 0.05 versus the ND SAL group; #p < 0.05 versus the HFD SAL group

The original article has been corrected.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vanessa Estato.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Estato, V., Obadia, N., Chateaubriand, P.H. et al. Correction: Semaglutide restores astrocyte-vascular interactions and blood-brain barrier integrity in a model of diet-induced metabolic syndrome. Diabetol Metab Syndr 17, 135 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13098-025-01703-x

Download citation

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13098-025-01703-x